Morgan Stanley Virtual Annual Global Healthcare Conference
Format: Fireside Chat and investor 1x1 meetings
Please find a link to the presentation here. A replay will be available for 90 days.
Format: Presentation and investor 1x1 meetings
All company presentations will be available on-demand beginning at
Please find a link to the presentation here.
A webcast of both presentations can also be accessed under “Events & Presentations” in the Investors section of the Company’s website, www.foghorntx.com
Foghorn® Therapeutics is discovering and developing a novel class of medicines targeting genetically determined dependencies within the chromatin regulatory system. Through its proprietary scalable Gene Traffic Control® platform, Foghorn is systematically studying, identifying and validating potential drug targets within the chromatin regulatory system. The company is developing multiple product candidates in oncology.
Investor Relations Contact:
Source: Foghorn Therapeutics, Inc.